These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
537 related articles for article (PubMed ID: 10440744)
21. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer. Tzai TS; Tsai YS; Chow NH Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007 [TBL] [Abstract][Full Text] [Related]
22. Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. Shapiro GI; Edwards CD; Kobzik L; Godleski J; Richards W; Sugarbaker DJ; Rollins BJ Cancer Res; 1995 Feb; 55(3):505-9. PubMed ID: 7834618 [TBL] [Abstract][Full Text] [Related]
23. Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma. Burke L; Flieder DB; Guinee DG; Brambilla E; Freedman AN; Bennett WP; Jones RT; Borkowski A; Caporaso NA; Fleming M; Trastek V; Pairolero P; Tazelaar H; Midthun D; Jett JR; Liotta LA; Travis WD; Harris CC Clin Cancer Res; 2005 Jan; 11(1):232-41. PubMed ID: 15671551 [TBL] [Abstract][Full Text] [Related]
24. RB growth control evasion in lung cancer. Caputi M; Esposito V; Groger AM; De Luca A; Pacilio C; Dekan G; Giordano GG; Baldi F; Wolner E; Giordano A Anticancer Res; 1998; 18(4A):2371-4. PubMed ID: 9703881 [TBL] [Abstract][Full Text] [Related]
25. Cyclin-dependent kinase inhibitor p27Kip1 expression and interaction with other cell cycle-associated proteins in mammary carcinoma. Gillett CE; Smith P; Peters G; Lu X; Barnes DM J Pathol; 1999 Jan; 187(2):200-6. PubMed ID: 10365095 [TBL] [Abstract][Full Text] [Related]
26. Alterations of the p16/Rb/cyclin-D1 pathway in vulvar carcinoma, vulvar intraepithelial neoplasia, and lichen sclerosus. Lerma E; Esteller M; Herman JG; Prat J Hum Pathol; 2002 Nov; 33(11):1120-5. PubMed ID: 12454817 [TBL] [Abstract][Full Text] [Related]
27. Concomitant analysis of p16/INK4, cyclin D1, and retinoblastoma protein expression in esophageal squamous cell carcinoma. Nakamura T; Ide H; Eguchi R; Hayashi K; Takasaki K Hepatogastroenterology; 2003; 50(53):1321-6. PubMed ID: 14571727 [TBL] [Abstract][Full Text] [Related]
28. Differential expression of key cell cycle genes (p16/cyclin D1/pRb) in head and neck squamous carcinomas. Lai S; El-Naggar AK Lab Invest; 1999 Mar; 79(3):255-60. PubMed ID: 10092061 [TBL] [Abstract][Full Text] [Related]
29. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features. Ioachim E Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860 [TBL] [Abstract][Full Text] [Related]
30. Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer. Keum JS; Kong G; Yang SC; Shin DH; Park SS; Lee JH; Lee JD Br J Cancer; 1999 Sep; 81(1):127-32. PubMed ID: 10487623 [TBL] [Abstract][Full Text] [Related]
31. [The expression of P16 and Rb proteins in 106 cases of lung cancer]. Qin J; Chen G; Wang X Zhonghua Jie He He Hu Xi Za Zhi; 2000 Oct; 23(10):588-90. PubMed ID: 11372380 [TBL] [Abstract][Full Text] [Related]
32. Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers. Geradts J; Fong KM; Zimmerman PV; Maynard R; Minna JD Clin Cancer Res; 1999 Apr; 5(4):791-800. PubMed ID: 10213214 [TBL] [Abstract][Full Text] [Related]
33. Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus. Takeuchi H; Ozawa S; Ando N; Shih CH; Koyanagi K; Ueda M; Kitajima M Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2229-36. PubMed ID: 9815619 [TBL] [Abstract][Full Text] [Related]
34. [The expression of P16, Rb and cyclin D1 and biological behavior of laryngeal cancer]. Dai S; Huang W; Gan X Zhonghua Er Bi Yan Hou Ke Za Zhi; 1997 Oct; 32(5):299-301. PubMed ID: 10743098 [TBL] [Abstract][Full Text] [Related]
35. Prognostic role of cyclin D1 in non small cell lung cancer: an immunohistochemical analysis. Caputi M; De Luca L; Papaccio G; D'Aponte A; Cavallotti I; Scala P; Scarano F; Manna M; Gualdiero L; De Luca B Eur J Histochem; 1997; 41(2):133-8. PubMed ID: 9271706 [TBL] [Abstract][Full Text] [Related]
36. [The cyclin A, B1, D1 and E expression in advanced non-small cell lung cancer--stages IIIB-IV (preliminary report)]. Kosacka M; Piesiak P; Porebska I; Korzeniewska A; Jankowska R Pol Merkur Lekarski; 2011 Apr; 30(178):253-8. PubMed ID: 21595169 [TBL] [Abstract][Full Text] [Related]
37. Abnormal expression of cell cycle regulatory proteins in ductal and lobular carcinomas of the breast. Geradts J; Ingram CD Mod Pathol; 2000 Sep; 13(9):945-53. PubMed ID: 11007034 [TBL] [Abstract][Full Text] [Related]
38. Expression of cyclin D1 but not of cyclin E is an indicator of poor prognosis in small adenocarcinomas of the lung. Ikehara M; Oshita F; Ito H; Ohgane N; Suzuki R; Saito H; Yamada K; Noda K; Mitsuda A; Kameda Y Oncol Rep; 2003; 10(1):137-9. PubMed ID: 12469159 [TBL] [Abstract][Full Text] [Related]
39. [Expression of cyclin D1 and vascular endothelial growth factor(VEGF) in non-small cell lung carcinoma and their association with the prognosis]. Liang RY; Liao ZS; Jiang SP; Zhang W; Li JG; Zheng DH Ai Zheng; 2003 Jan; 22(1):86-90. PubMed ID: 12561444 [TBL] [Abstract][Full Text] [Related]
40. p16INK4A in oral squamous cell carcinomas--a correlation with biological behaviors: immunohistochemical and FISH analysis. Suzuki H; Sugimura H; Hashimoto K J Oral Maxillofac Surg; 2006 Nov; 64(11):1617-23. PubMed ID: 17052587 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]